Related Experiment Video
Updated: May 17, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Elevated MTORC1 signaling and impaired autophagy
Fresnida J Ramos1, Matt Kaeberlein, Brian K Kennedy
1Department of Pathology, University of Washington, Seattle, WA, USA.
Autophagy
|October 16, 2012
Summary
Mutations in the LMNA gene cause muscular dystrophy and dilated cardiomyopathy by impairing autophagy. Inhibiting MTORC1 signaling with rapalogs can restore this process and improve cardiac function.
Area of Science:
- Cell Biology
- Genetics
- Cardiovascular Medicine
Background:
- A-type lamins, encoded by the LMNA gene, are crucial intermediate filament proteins forming the nuclear lamina.
- Mutations in LMNA cause diverse genetic disorders, including dilated cardiomyopathy and muscular dystrophies.
- These conditions are modeled in lmna (-/-) mice and mice expressing human disease mutations.
Purpose of the Study:
- To investigate the molecular mechanisms underlying cardiac and skeletal muscle pathology in lmna (-/-) mice.
- To explore the therapeutic potential of MTORC1 inhibition in LMNA-associated diseases.
Main Methods:
- Utilized lmna (-/-) mouse models and mice engineered with human LMNA mutations.
- Assessed MTORC1 signaling, autophagic flux, cardiac function, and survival.
- Administered rapalogs to inhibit MTORC1 signaling.
Main Results:
- Elevated MTORC1 signaling and impaired autophagic flux were identified as key contributors to muscle pathology in lmna (-/-) mice.
- Similar autophagic impairments were observed in mice with LMNA H222P mutations and human cardiac tissue.
- MTORC1 inhibition with rapalogs successfully restored autophagic flux and improved cardiac function in mouse models.
- Rapalogs extended survival in lmna (-/-) mice.
Conclusions:
- Impaired autophagic flux due to elevated MTORC1 signaling is a central mechanism in LMNA-related cardiomyopathies and muscular dystrophies.
- MTORC1 inhibition represents a promising therapeutic strategy for these debilitating genetic disorders.
- These findings reinforce the link between disrupted autophagy and human disease pathogenesis.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...